Preclinical studies

Preclinical studies bridge the gap between early phase discovery research and the clinical evaluation of a drug in human subjects. Comprehensive assessment of pathological changes is often vital in the evaluation of preclinical studies, in order to inform the critical decision making process of proceeding with a drug or other therapeutic modality to the clinical evaluation stage.

We offer expert, fast and efficient service including:

• Evaluation of study tissue samples, including morphological analysis of haematoxylin and eosin stained sections and analysis of special stains, immunohistochemistry and immunofluorescence for specific marker evaluation
• Research consultation service including advice on study design and parameters for pathological evaluation
• Preparation of full report spreadsheets tailored to customer needs and regulatory requirements.
• GLP certified and fully conversant with GLP guidelines.